Who we are?

Pierre Fabre is the 3rd largest French pharmaceutical group. In 2013, its sales reached €2.008 Billion, with international revenues accounting for 56%. Founded and its headquarters still based in the South-west of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in over 130 countries.

Covering all aspects of healthcare, from prescription drugs and OTC products to dermo-cosmetics, Pierre Fabre Laboratories employ over 10,000 people worldwide. In 2013, Pierre Fabre allocated more than 17% of its drug revenues to R&D, focusing on three main areas: oncology, dermatology and neuropsychiatry.

News

Pierre Fabre Médicament announced that it had obtained marketing authorization (MA) in China from the CFDA (China Food and Drug Administration) for NAVELBINE®Oral in monotherapy or in association, for the treatment of locally advanced, unresectable, non-small cell lung cancer and for advanced breast cancer.

Select country and language: